TREM2 as an evolving therapeutic target in Alzheimer's disease.
作者信息
George Jacob
机构信息
Cognyxx Pharmaceuticals, Tel Aviv Israel and Kaplan Heart Center, Rehovot, Israel.
出版信息
Neural Regen Res. 2023 Dec;18(12):2680-2681. doi: 10.4103/1673-5374.371360.
Abstract
摘要
相似文献
1
TREM2 as an evolving therapeutic target in Alzheimer's disease.
Neural Regen Res. 2023 Dec;18(12):2680-2681. doi: 10.4103/1673-5374.371360.
2
The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
Lancet Neurol. 2018 Aug;17(8):721-730. doi: 10.1016/S1474-4422(18)30232-1. Epub 2018 Jul 17.
3
TREM2 and the neuroimmunology of Alzheimer's disease.
Biochem Pharmacol. 2014 Apr 15;88(4):495-8. doi: 10.1016/j.bcp.2013.11.021. Epub 2013 Dec 16.
4
Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer's disease.
Cell Rep. 2022 May 31;39(9):110883. doi: 10.1016/j.celrep.2022.110883.
5
TREM2 in Alzheimer's Disease: Microglial Survival and Energy Metabolism.
Front Aging Neurosci. 2018 Nov 23;10:395. doi: 10.3389/fnagi.2018.00395. eCollection 2018.
6
Treadmill exercise improve recognition memory by TREM2 pathway to inhibit hippocampal microglial activation and neuroinflammation in Alzheimer's disease model.
Physiol Behav. 2022 Jul 1;251:113820. doi: 10.1016/j.physbeh.2022.113820. Epub 2022 Apr 19.
7
The Alzheimer's Disease-Associated R47H Variant of TREM2 Has an Altered Glycosylation Pattern and Protein Stability.
Front Neurosci. 2017 Jan 18;10:618. doi: 10.3389/fnins.2016.00618. eCollection 2016.
8
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
Mol Neurodegener. 2018 Sep 6;13(1):49. doi: 10.1186/s13024-018-0280-6.
9
TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease.
Int J Mol Sci. 2023 May 11;24(10):8626. doi: 10.3390/ijms24108626.
10
Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Curr Alzheimer Res. 2019;16(13):1216-1229. doi: 10.2174/1567205016666190903102822.
引用本文的文献
1
in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting.
Int J Mol Sci. 2025 Jul 22;26(15):7057. doi: 10.3390/ijms26157057.
2
Corticosterone effects induced by stress and immunity and inflammation: mechanisms of communication.
Front Endocrinol (Lausanne). 2025 Mar 20;16:1448750. doi: 10.3389/fendo.2025.1448750. eCollection 2025.
3
Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium.
Alzheimers Dement. 2025 Feb;21(2):e14548. doi: 10.1002/alz.14548. Epub 2025 Jan 27.
4
Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival.
Mol Psychiatry. 2025 May;30(5):1985-1994. doi: 10.1038/s41380-024-02809-w. Epub 2024 Oct 29.
5
A Computational Approach in the Systematic Search of the Interaction Partners of Alternatively Spliced TREM2 Isoforms.
Int J Mol Sci. 2024 Sep 6;25(17):9667. doi: 10.3390/ijms25179667.
6
Microglia, Trem2, and Neurodegeneration.
Neuroscientist. 2025 Apr;31(2):159-176. doi: 10.1177/10738584241254118. Epub 2024 May 20.
本文引用的文献
1
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading.
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20220654. Epub 2022 Oct 11.
2
The Primary Microglial Leukodystrophies: A Review.
Int J Mol Sci. 2022 Jun 6;23(11):6341. doi: 10.3390/ijms23116341.
3
Soluble TREM2: Innocent bystander or active player in neurological diseases?
Neurobiol Dis. 2022 Apr;165:105630. doi: 10.1016/j.nbd.2022.105630. Epub 2022 Jan 15.
4
Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models.
J Neuroinflammation. 2021 Jan 9;18(1):19. doi: 10.1186/s12974-020-01980-5.
5
Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition.
J Neuroinflammation. 2020 Aug 14;17(1):238. doi: 10.1186/s12974-020-01915-0.
6
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model.
J Exp Med. 2020 Sep 7;217(9). doi: 10.1084/jem.20200785.
7
The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway.
Cell. 2020 Jun 11;181(6):1207-1217. doi: 10.1016/j.cell.2020.05.003.
8
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region.
EMBO Mol Med. 2020 Apr 7;12(4):e11227. doi: 10.15252/emmm.201911227. Epub 2020 Mar 10.
9
TREM2 - a key player in microglial biology and Alzheimer disease.
Nat Rev Neurol. 2018 Nov;14(11):667-675. doi: 10.1038/s41582-018-0072-1.
10
TREM2 variants in Alzheimer's disease.
N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851. Epub 2012 Nov 14.
Zotero 插件